Artesunate, imatinib, and infliximab in COVID-19: A rapid review and meta-analysis of current evidence.

Bahman Amani Sara Zareei Behnam Amani Mahsa Zareei Neda Zareei Rouhollah Shabestan Arash Akbarzadeh

Published in: Immunity, inflammation and disease (2022)

In the present, limited evidence exists for the efficacy and safety of artesunate, imatinib, and infliximab in patients with COVID-19. The findings of WHO's Solidarity international trial will provide further information regarding these therapeutic interventions.

Keyphrases

chronic myeloid leukemia
ulcerative colitis
coronavirus disease
sars cov
phase iii
clinical trial
physical activity
phase ii
health information
loop mediated isothermal amplification
healthcare
patients with inflammatory bowel disease